Interfyl® Human Connective Tissue Matrix Protection Status

Interfyl® Human Connective Tissue Matrix is an allogenic decellularized, particulate human placental connective tissue matrix consisting of natural human structural and biochemical extracellular matrix components. The transplanted matrix retains its fundamental structural and functional characteristics of connective tissue extracellular matrix, providing mechanical/structural support and elasticity. Provides a framework for incorporation by the recipient’s tissues and cells.

Celularity, Inc. is a biotechnology company that produces cells and tissues derived from the postpartum placenta. Its portfolio of products supports the body's ability to regenerate tissue and includes BIOVANCE® Human Amniotic Membrane Allograft, Interfyl® Human Connective Tissue Matrix and UltraMIST® System.

(844) 963-2273

Important Notice: The contents of the website such as text, graphics, images, and other materials contained on the website ("Content") are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. The content is not intended to substitute manufacturer instructions. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or product usage. Refer to the Legal Notice for express terms of use.